Skip to content
DraconiticResearch
Search Sources API
224,311 studies31 sourcesUpdated 1 h ago
Peer-reviewedLicence not statedBMJ Open

Barriers and facilitators for implementing active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer in Dutch hospitals: a qualitative study

  • Sanjiv S G Gangaram Panday1
  • Yumin Kim1
  • Erwin Ista2,3
  • Bianca Mostert4
  • Leonieke Kranenburg5
  • J Jan B van Lanschot1
  • Manon C W Spaander6
  • Jan Willem T Dekker7
  • Joos Heisterkamp8
  • Grard A P Nieuwenhuijzen9
  • Jean-Pierre Pierie10
  • Camiel Rosman11
3 more authors
  • Johanna W van Sandick12
  • Sjoerd M Lagarde1
  • Bas P L Wijnhoven1
12 affiliations
  1. 1Department of Surgery, Erasmus MC Cancer Institute, Erasmus MC University Medical Centre, Rotterdam, The Netherlands
  2. 2Department of Internal Medicine, Division of Nursing Science, Erasmus MC University Medical Centre, Rotterdam, The Netherlands
  3. 3Department of Neonatal and Pediatric Intensive Care, Division of Pediatric lntensive Care, Sophia Children’s Hospital, Erasmus MC University Medical Centre, Rotterdam, The Netherlands
  4. 4Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus MC University Medical Centre, Rotterdam, The Netherlands
  5. 5Department of Psychiatry, Erasmus MC University Medical Center Rotterdam, Rotterdam, The Netherlands
  6. 6Department of Gastroenterology and Hepatology, Erasmus MC University Medical Centre, Rotterdam, The Netherlands
  7. 7Department of Surgery, Reinier de Graaf Gasthuis, Delft, The Netherlands
  8. 8Department of Surgery, Elisabeth Tweesteden Hospital, Tilburg, The Netherlands
  9. 9Department of Surgery, Catharina Hospital, Eindhoven, North Brabant, The Netherlands
  10. 10Department of Surgery, Frisius MC, Leeuwarden, The Netherlands
  11. 11Department of Surgery, Radboud University Medical Centre, Nijmegen, The Netherlands
  12. 12Department of Surgical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands
Open at sourceDOICite

Related

  1. Early Recurrence Patterns After Neoadjuvant Chemoradiotherapy and Chemoimmunotherapy in Oesophageal Squamous Cell Carcinoma: A Multicentre Study
    Cien Sun, Chunji Chen, Hua Sun +32
    European Journal of Cardio-Thoracic SurgeryPeer-reviewedCC BY-NC 4.0Full textSurgery & anaesthesiaPMC
  2. Identification of NUDT6 and LINGO1 as candidate genes for nCRT-associated signatures to neoadjuvant chemoradiotherapy in rectal cancer patients
    Qian Wang, Guangpeng Shen, Juntao Wang +3
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textOncologyCrossref
  3. Short-Term Outcomes and Stoma-Related Morbidity of Diverting Ileostomy After Laparoscopic Total Mesorectal Excision Following Neoadjuvant Chemoradiotherapy for Mid- and Distal Rectal Cancer: A Retrospective Single-Center Study
    Murat Derebey, Ufuk Karabacak, Ismail Alper Tarim +3
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. A decade of implementing comprehensive child development services in Northwest Iran: a qualitative study of provider perspectives on barriers and facilitators
    Mehrdad Amir-Behghadami, Jafar Sadegh Tabrizi, Seifollah Heidarabadi
    BMC Public HealthPeer-reviewedCC BY-NC-ND 4.0Epidemiology & public healthCrossref
  5. Neoadjuvant toripalimab plus concurrent chemoradiotherapy for locally advanced adenocarcinoma of the esophagogastric junction: a phase II trial
    Yongheng Li, Rongxu Du, Jianhao Geng +25
    BMC MedicinePeer-reviewedCC BY-NC-ND 4.0Surgery & anaesthesiaCrossref

Cite

BibTeXRIS
BibTeX
@article{panday2026barriers,
  title = {{Barriers and facilitators for implementing active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer in Dutch hospitals: a qualitative study}},
  author = {Sanjiv S G Gangaram Panday and Yumin Kim and Erwin Ista and Bianca Mostert and Leonieke Kranenburg and J Jan B van Lanschot and Manon C W Spaander and Jan Willem T Dekker and Joos Heisterkamp and Grard A P Nieuwenhuijzen and Jean-Pierre Pierie and Camiel Rosman and Johanna W van Sandick and Sjoerd M Lagarde and Bas P L Wijnhoven},
  journal = {BMJ Open},
  year = {2026},
  month = nov,
  doi = {10.1136/bmjopen-2026-119825},
  url = {https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2026-119825},
}
RIS
TY  - JOUR
TI  - Barriers and facilitators for implementing active surveillance after neoadjuvant chemoradiotherapy for oesophageal cancer in Dutch hospitals: a qualitative study
AU  - Sanjiv S G Gangaram Panday
AU  - Yumin Kim
AU  - Erwin Ista
AU  - Bianca Mostert
AU  - Leonieke Kranenburg
AU  - J Jan B van Lanschot
AU  - Manon C W Spaander
AU  - Jan Willem T Dekker
AU  - Joos Heisterkamp
AU  - Grard A P Nieuwenhuijzen
AU  - Jean-Pierre Pierie
AU  - Camiel Rosman
AU  - Johanna W van Sandick
AU  - Sjoerd M Lagarde
AU  - Bas P L Wijnhoven
PY  - 2026
DA  - 2026/11/11
JO  - BMJ Open
DO  - 10.1136/bmjopen-2026-119825
UR  - https://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2026-119825
SN  - 2044-6055
SN  - 2044-6055
ER  -